Free Trial

Raymond James Financial Inc. Acquires Shares of 12,296 Trupanion, Inc. (NASDAQ:TRUP)

Trupanion logo with Finance background
Remove Ads

Raymond James Financial Inc. acquired a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 12,296 shares of the financial services provider's stock, valued at approximately $593,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC raised its holdings in Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock valued at $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Baillie Gifford & Co. increased its stake in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after purchasing an additional 147,341 shares during the last quarter. Wellington Management Group LLP lifted its position in Trupanion by 4.4% during the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider's stock worth $142,475,000 after buying an additional 142,156 shares during the period. Hosking Partners LLP lifted its position in Trupanion by 52.5% during the fourth quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider's stock worth $10,253,000 after buying an additional 73,203 shares during the period. Finally, Barclays PLC boosted its stake in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after buying an additional 47,262 shares during the last quarter.

Insiders Place Their Bets

In related news, CEO Margaret Tooth sold 2,294 shares of the firm's stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $3,728,629.76. This trade represents a 1.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Emily Dreyer sold 14,025 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the sale, the senior vice president now directly owns 27,645 shares of the company's stock, valued at $895,974.45. This trade represents a 33.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 29,792 shares of company stock worth $989,442 over the last quarter. 5.50% of the stock is owned by corporate insiders.

Remove Ads

Trupanion Trading Up 1.9 %

Shares of NASDAQ:TRUP traded up $0.65 during trading on Friday, reaching $35.62. 612,520 shares of the stock were exchanged, compared to its average volume of 657,182. The firm's 50-day moving average price is $37.85 and its 200 day moving average price is $45.80. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of -154.87, a price-to-earnings-growth ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $337.31 million for the quarter, compared to analysts' expectations of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, sell-side analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on TRUP shares. Piper Sandler cut their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus cut their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $46.60.

Read Our Latest Stock Report on TRUP

Trupanion Company Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads